Tuning-Forum

herrwaq71 · Gość

Hi all!
Fisher et al. discuss ensuring that appropriate pharmaceutical [link widoczny dla zalogowanych] care continues with increasing numbers of day-case cancer patients. The increase in patients being treated with oral chemotherapy at day-case chemotherapy [link widoczny dla zalogowanych] clinics has increased and clinical monitoring is needed in primary care in order to minimise the risks associated with the medicines used. Detailed information about monitoring requirements needs to be conv
eyed from the day-case clinic to the patients GP and community pharmacist, and both need to be aware of the therapeutic plan for the patient, the management of potential toxicities and possible drug interactions.
just really it